Anzeige
Mehr »
Mittwoch, 09.07.2025 - Börsentäglich über 12.000 News
Schwergewicht aus London investiert Millionen in australisches Goldprojekt - was Anleger jetzt wissen müssen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
358 Leser
Artikel bewerten:
(2)

$1.3 Billion Quantum Computing in Healthcare Market Poised for 37.9% CAGR Growth | MarketsandMarkets

DELRAY BEACH, Fla., July 9, 2025 /PRNewswire/ --

What's fueling a $1.3 billion quantum leap in healthcare?

The global quantum computing in healthcare market, valued at US$191.3 million in 2024, stood at US$265.9 million in 2025 and is projected to advance at a resilient CAGR of 37.9% from 2025 to 2030, culminating in a forecasted valuation of US$1324.2 million by the end of the period. This acceleration isn't speculative-it's driven by urgent healthcare demands, exponential data growth, and a race toward AI-powered personalization in medicine. For C-level executives, this is no longer a question of 'if', but 'how fast can we capture this value'?

MarketsandMarkets Logo

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=41524710

Why is quantum computing redefining the healthcare market landscape?

In fields like genomics, drug development, and clinical diagnostics, conventional computing hits a wall. Quantum systems break through-modeling molecular complexity, running probabilistic simulations, and enabling precise diagnostics in seconds rather than weeks. When paired with AI, quantum computing becomes a force multiplier, unlocking faster treatments, predictive insights, and data-driven care at scale.

What does quantum computing solve in the $13 trillion global healthcare economy?

Healthcare inefficiencies-from slow drug discovery pipelines to poor diagnostic accuracy-cost billions. Quantum computing dramatically reduces drug discovery timelines, enhances genomics analysis, and brings real-time modeling to clinical decisions. It's already reshaping how pharmaceutical and biotech firms design molecules, conduct trials, and bring therapies to market faster.

Where are the most promising markets for quantum healthcare adoption?

Rapid digitalization and rising healthcare needs are positioning India, China, Brazil, Southeast Asia, and the Middle East as next-gen quantum hubs. These regions are benefiting from government-backed quantum initiatives, academic-industrial partnerships, and cost-effective infrastructure, enabling quantum healthcare innovation without Western regulatory drag.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=41524710

Who's dominating the quantum healthcare market-and who's entering the race?

Market leaders include IBM, AWS, IonQ, Google, Rigetti, Microsoft, and Quantinuum. IBM's Quantum System One is operational at Cleveland Clinic. IonQ, NVIDIA, and AstraZeneca are building real-world workflows in quantum-enhanced drug discovery. Startups like Xanadu, Pasqal, and Qubit Pharmaceuticals are pushing quantum boundaries in AI diagnostics and clinical modeling. Together, the top players command 50-60% of global market share.

What are the real-world challenges-and how do we unlock scale?

It's not just about hardware-it's about ROI, trust, and training. Quantum still battles high error rates, steep costs, and talent shortages. Organizations that succeed will invest in quantum-literate R&D teams, cloud-based hybrid workflows, and partnerships that bridge the lab-to-clinic gap. The true barrier is speed of adoption, not technical readiness.

What should enterprise leaders really be asking right now?
Not "Is quantum computing viable in healthcare?" but:

  • How fast can we scale quantum pilots into production-level use?
  • What ROI frameworks prove quantum's value to stakeholders and boards?
  • Where can we reallocate capital from classical to quantum-aligned pipelines?
  • Which partners will drive us ahead of the competition-before they do?

Final Thought: In a Data-Driven Healthcare Market, Quantum Is No Longer Experimental-It's Economical.
Precision is no longer a luxury-it's the competitive edge. With billions at stake in R&D savings, patient outcomes, and faster go-to-market strategies, quantum computing is the most investable technology in healthcare's next decade. It brings computational power, clinical intelligence, and commercialization potential under one scalable platform.

Quantum isn't just transforming healthcare-it's rewriting the rules.

For more information, Inquire Now!

Related Reports:

AI in Telehealth & Telemedicine Market

AI in Remote Patient Monitoring (RPM) Market

IoT Medical Devices Market

Healthcare Cloud Computing Market

Remote Patient Monitoring Market

Get access to the latest updates on Top Companies in Quantum Computing for Healthcare and Quantum Computing in Healthcare Market Size

About MarketsandMarkets:

MarketsandMarkets has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/1-3-billion-quantum-computing-in-healthcare-market-poised-for-37-9-cagr-growth--marketsandmarkets-302501033.html

© 2025 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.